Brentuximab vedotin therapy for cutaneous lesions in T-prolymphocytic leukemia: a case report

We present an 88-year-old male with simultaneous T-cell prolymphocytic leukemia and stable smoldering myeloma with excellent initial response to three months of alemtuzumab. The patient relapsed at twelve months with severe cutaneous disease. Biopsy of a representative plaque demonstrated CD30 posit...

Full description

Bibliographic Details
Main Authors: Jordan Senchak, Peter Pickens
Format: Article
Language:English
Published: MDPI AG 2016-09-01
Series:Hematology Reports
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/6593